These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34848562)

  • 21. AL amyloidosis: advances in diagnostics and treatment.
    Ryšavá R
    Nephrol Dial Transplant; 2019 Sep; 34(9):1460-1466. PubMed ID: 30299492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and organ distribution of leukocyte chemotactic factor 2 amyloidosis (ALECT2) among decedents in New Mexico.
    Larsen CP; Beggs ML; Wilson JD; Lathrop SL
    Amyloid; 2016 Jun; 23(2):119-23. PubMed ID: 26912093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryo-EM structure of a human LECT2 amyloid fibril reveals a network of polar ladders at its core.
    Richards LS; Flores MD; Zink S; Schibrowsky NA; Sawaya MR; Rodriguez JA
    Structure; 2023 Nov; 31(11):1386-1393.e3. PubMed ID: 37657439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrence of leukocyte chemotactic factor 2-associated amyloidosis and autoimmune diseases: A case report.
    Wang S; Yu XJ; Li DY; Xu J; Wang SX
    Front Immunol; 2022; 13():966591. PubMed ID: 36059556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
    Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
    Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor-Derived ALECT2 Amyloidosis and Recurrent Fibrillary Glomerulonephritis in a Transplant Allograft.
    Nasr SH; Chavez O; Dasari S; Theis JD; Vrana JA; Fatima H; Fu L; Baliga RS; McPhail ED
    Kidney Med; 2021; 3(3):433-437. PubMed ID: 34136788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic Identification and Clinicopathologic Characterization of Splenic Amyloidosis.
    Chiu A; Dasari S; Kurtin PJ; Theis JD; Vrana JA; Rech KL; Dao LN; Howard MT; Dalland JC; McPhail ED
    Am J Surg Pathol; 2023 Jan; 47(1):74-80. PubMed ID: 35968972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States.
    Mereuta OM; Theis JD; Vrana JA; Law ME; Grogg KL; Dasari S; Chandan VS; Wu TT; Jimenez-Zepeda VH; Fonseca R; Dispenzieri A; Kurtin PJ; Dogan A
    Blood; 2014 Mar; 123(10):1479-82. PubMed ID: 24415538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases.
    Said SM; Sethi S; Valeri AM; Leung N; Cornell LD; Fidler ME; Herrera Hernandez L; Vrana JA; Theis JD; Quint PS; Dogan A; Nasr SH
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1515-23. PubMed ID: 23704299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alect2 amyloidosis: primum non nocere (first, do no harm).
    Picken MM
    Kidney Int; 2014 Aug; 86(2):229-32. PubMed ID: 25079018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and laboratory profile of renal amyloidosis: A single-center experience.
    Engineer DP; Kute VB; Patel HV; Shah PR
    Saudi J Kidney Dis Transpl; 2018; 29(5):1065-1072. PubMed ID: 30381502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.
    Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ
    Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ALECT2 amyloidosis with concurrent IgG4-related interstitial nephritis, membranous nephropathy and diabetic kidney disease: a case report and literature review.
    Shaheen M; Bharat A; Friedman AN; Guo S
    J Nephrol; 2024 Apr; ():. PubMed ID: 38630340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte.
    Valdés-Lagunes DA; Méndez-Pérez RA; de la Cruz MA; Uribe-Uribe NO; Mejía-Vilet JM
    Clin Nephrol; 2020 Nov; 94(5):266-270. PubMed ID: 32870148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review.
    Karam S; Haidous M; Royal V; Leung N
    Kidney Int; 2023 Mar; 103(3):473-484. PubMed ID: 36502873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis.
    Angel-Korman A; Jaberi A; Sanchorawala V; Havasi A
    Amyloid; 2020 Mar; 27(1):17-24. PubMed ID: 31595786
    [No Abstract]   [Full Text] [Related]  

  • 39. LECT2 Amyloidosis in Kidney Transplantation: A Report of 5 Cases.
    Mejia-Vilet JM; Cárdenas-Mastrascusa LR; Palacios-Cebreros EJ; Reyes-Macedo M; Portilla-Jiménez A; Morales-Buenrostro LE; Cohen-Bucay A; Niño-Cruz JA; Uribe-Uribe NO
    Am J Kidney Dis; 2019 Oct; 74(4):563-566. PubMed ID: 31155323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukocyte Derived Chemotaxin 2 (ALECT2) Amyloidosis.
    Kulkarni U; Valson A; Korula A; Mathews V
    Mediterr J Hematol Infect Dis; 2015; 7(1):e2015043. PubMed ID: 26185608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.